rs150393358
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_006939.4(SOS2):c.3769A>G(p.Asn1257Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000221 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006939.4 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 9Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -14 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SOS2 | ENST00000216373.10 | c.3769A>G | p.Asn1257Asp | missense_variant | Exon 23 of 23 | 1 | NM_006939.4 | ENSP00000216373.5 | ||
| SOS2 | ENST00000543680.5 | c.3670A>G | p.Asn1224Asp | missense_variant | Exon 22 of 22 | 1 | ENSP00000445328.1 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152092Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000159 AC: 40AN: 251484 AF XY: 0.000199 show subpopulations
GnomAD4 exome AF: 0.000225 AC: 329AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.000234 AC XY: 170AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000178 AC: 27AN: 152092Hom.: 0 Cov.: 31 AF XY: 0.000162 AC XY: 12AN XY: 74294 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
Variant summary: SOS2 c.3769A>G (p.Asn1257Asp) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00016 in 251484 control chromosomes, predominantly at a frequency of 0.00033 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 132 fold of the estimated maximal expected allele frequency for a pathogenic variant in SOS2 causing Noonan Syndrome phenotype (2.5e-06). c.3769A>G has been reported in the literature in at least an individual affected with Noonan Syndrome (example: Cordeddu_2015). This report however, does not provide unequivocal conclusions about association of the variant with Noonan Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26173643, 27920155). ClinVar contains an entry for this variant (Variation ID: 542399). Based on the evidence outlined above, the variant was classified as likely benign. -
- -
Noonan syndrome 9 Benign:2
- -
- -
SOS2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
SOS2: BP4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at